Literature DB >> 21447278

Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).

Amy M Burrell1, Adam E Handel, Sreeram V Ramagopalan, George C Ebers, Julia M Morahan.   

Abstract

Multiple sclerosis (MS) is a complex disorder of the central nervous system characterized by demyelination, axonal loss, and inflammation. The cause of MS is currently unknown although genetic and environmental factors contribute to etiology. The relative importance of each has been disputed; however, now it is clear that much of the disease results from the interaction of the environment and the genetics. Epigenetic modifications within the major histocompatibility complex (MHC) likely mediate interactions at this locus with current known environmental risk factors--vitamin D, Epstein-Barr virus, and smoking. Maternal parent-of-origin effects, month of birth effects and transgenerational differences in allele frequency are also evident in MS and may be mediated by sex-specific epigenetic mechanisms. Differences in epigenetic marks characterize monozygotic twin pairs and may explain discordance. There is promise of potential therapeutic strategies to be found in the epigenetic mechanisms at work in MS.

Entities:  

Mesh:

Year:  2011        PMID: 21447278

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  14 in total

Review 1.  Environmental factors acting during development to influence MS risk: insights from animal studies.

Authors:  Dimitry N Krementsov; Cory Teuscher
Journal:  Mult Scler       Date:  2013-09-27       Impact factor: 6.312

2.  Modeling month-season of birth as a risk factor in mouse models of chronic disease: from multiple sclerosis to autoimmune encephalomyelitis.

Authors:  Jacob D Reynolds; Laure K Case; Dimitry N Krementsov; Abbas Raza; Rose Bartiss; Cory Teuscher
Journal:  FASEB J       Date:  2017-03-14       Impact factor: 5.191

3.  Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.

Authors:  Chiharu Kumagai; Bernadette Kalman; Frank A Middleton; Tamara Vyshkina; Paul T Massa
Journal:  J Neuroimmunol       Date:  2012-03-27       Impact factor: 3.478

Review 4.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

5.  Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.

Authors:  D Pisa; R Alonso; F J Jiménez-Jiménez; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-16       Impact factor: 3.267

6.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 7.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

8.  Blood pressure normalization post-jugular venous balloon angioplasty.

Authors:  Zohara Sternberg; Prabhjot Grewal; Steven Cen; Frances DeBarge-Igoe; Jinhee Yu; Michael Arata
Journal:  Phlebology       Date:  2013-11-19       Impact factor: 1.740

9.  Multiple sclerosis and the blood-central nervous system barrier.

Authors:  Alan M Palmer
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-01-15

10.  Gene-specific DNA methylation association with serum levels of C-reactive protein in African Americans.

Authors:  Yan V Sun; Alicia Lazarus; Jennifer A Smith; Yu-Hsuan Chuang; Wei Zhao; Stephen T Turner; Sharon L R Kardia
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.